Food and Drug Lipitor 80 mg approved the medication in Its active ingredient is atorvastatin calcium. By lowering the amount of LDL in the blood, the medication prevents atherosclerosis, a condition ...
Orlando, FL - Intensive lipid-lowering treatment with atorvastatin (Lipitor ®, Pfizer) 80 mg daily completely halted the progression of atherosclerosis, whereas a moderate lipid-lowering regimen of ...
Patients treated with Lipitor® (atorvastatin calcium) 80 mg had a significant 55 percent reduction in levels of high-sensitivity C-reactive protein (hsCRP), while those taking Lipitor 10 mg had a ...
Atorvastatin is known as an adjunct to nondrug hookworms i. Atorvastatin in atrial combination with amlodipine is lipitor 80 mg generic price in people for whom treatment with both atorvastatin and a ...
When added to low-dose atorvastatin a much-discussed new monoclonal antibody to PCSK9 significantly lowers cholesterol more effectively than atorvastatin alone, according to a phase 2 study published ...
Cholesterol disorders affect millions of people globally and are among the leading risk factors for cardiovascular diseases, including heart attack and stroke. Statins are the first-line therapy for ...
Press Release: Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease NEW YORK, March 7 -- Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved ...
ORLANDO-In a study of 10,001 patients with stable coronary disease, treatment with high dose atorvastatin (Lipitor) to mean LDL levels of 77 mg/dL was associated with a 22% reduction in risk of major ...
...high-dose statin therapy is associated with... a 12% increased risk of new-onset diabetes... The results of a meta-analysis indicate that high-dose statin therapy is associated with improved ...
WASHINGTON, DC—Treating patients with high-dose atorvastatin does not lead to impairments in memory in healthy men and women who receive the lipid-lowering therapy, according to the results of a new ...
Please provide your email address to receive an email when new articles are posted on . New findings from the SPARCL trial showed that patients with prior stroke or transient ischemic attack ...
Patients treated with Lipitor® (atorvastatin calcium) 80 mg had a significant 55 percent reduction in levels of high-sensitivity C-reactive protein (hsCRP), while those taking Lipitor 10 mg had a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results